title: Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii.
abstract: Serial passage at low dilution of seven different wild-type dengue (DEN) viruses into primary dog kidney (PDK) cell cultures placed selective pressure that resulted in the following changes from parental phenotype: smaller plaques in LLC-MK2 cells, absent plaque formation in green monkey kidney cells, lack of a cytopathic effect in LLC-MK2 cells, shut-off of virus replication at high temperatures (temperature sensitivity), reduced virulence for rhesus monkeys manifested by reduced or absent viremia and/or absence of a secondary-type antibody response following homotypic challenge, and progressive increase in the mean day of death following intracerebral inoculation of sucking mice. Two DEN-1 strains showed most of these changes by the 15th PDK passage. Only one of two DEN-2 strains studied was carried to the 50th PDK passage at the University of Hawaii. For the latter strain, both the temperature of viral replicative shutoff and mouse neurovirulence were reduced. Three DEN-4 strains showed similar late-passage biologic marker changes. The observations made, although not exhaustive, provide laboratory correlates for virus strains that have shown reduced virulence but retained immunogenicity in humans. Candidate human vaccines have been prepared from five of the studied strains: DEN-1 (16007) at PDK 13, DEN-2 (16681 and S-16803) at PDK 50 or above, and DEN-4 (1036 and 341750) at PDK 48 and 20, respectively.
authors.affiliation: Department of Tropical Medicine and Medical Microbiology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA. halsteads@erols.com
authors.forename: Scott B
authors.initials: SB
authors.lastname: Halstead
authors.forename: Nyven J
authors.initials: NJ
authors.lastname: Marchette
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D003588:Cytopathogenic Effect, Viral; D003715:Dengue / Q000517:prevention & control*; D003716:Dengue Virus / Q000276:immunology* / Q000472:pathogenicity; D004285:Dogs; D005260:Female; D006254:Hawaii; D006801:Humans; D008297:Male; D012692:Serial Passage; D014495:Universities; D014613:Vaccines, Attenuated; D014765:Viral Vaccines; D014776:Virus Cultivation
chemical_list: D000914:Antibodies, Viral; D014613:Vaccines, Attenuated; D014765:Viral Vaccines